-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Amgen, Raises Price Target to $405

Benzinga·08/07/2026 20:07:20
Listen to the news
Citigroup analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $345 to $405.